Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-016115
Filing Date
2020-04-09
Accepted
2020-04-09 16:30:45
Documents
9
Period of Report
2020-05-19
Effectiveness Date
2020-04-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A nbix-def14a_20200519.htm DEF 14A 1934630
2 GRAPHIC gcmfo5e1lbxy000003.jpg GRAPHIC 1105
3 GRAPHIC gcmfo5e1lbxy000007.jpg GRAPHIC 4195
4 GRAPHIC gcmfo5e1lbxy000005.jpg GRAPHIC 46014
5 GRAPHIC gcmfo5e1lbxy000006.jpg GRAPHIC 29415
6 GRAPHIC gcmfo5e1lbxy000008.jpg GRAPHIC 3660
7 GRAPHIC gcmfo5e1lbxy000001.jpg GRAPHIC 2311
8 GRAPHIC gcmfo5e1lbxy000002.jpg GRAPHIC 1170
9 GRAPHIC gcmfo5e1lbxy000004.jpg GRAPHIC 1087
  Complete submission text file 0001564590-20-016115.txt   2059393
Mailing Address 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12780 EL CAMINO REAL SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Filer) CIK: 0000914475 (see all company filings)

EIN.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-22705 | Film No.: 20784808
SIC: 2836 Biological Products, (No Diagnostic Substances)